the BIOSTACK
Investing in the architecture of life
the new era of engineering
The most important technologies are often invisible.
The 20th century was built on the electron.
From semiconductors and computing to software and the internet, our modern world emerged because humanity learned how to understand, manipulate, and scale the movement of electrons.
The 21st century will increasingly be built on the cell.
Life itself is becoming engineerable.
Advances in artificial intelligence, sequencing, synthetic biology, gene editing, cellular engineering, robotics, and computational chemistry are transforming biology from an observational science into an engineering discipline. For the first time in history, we can systematically read, write, and reprogram the code of life.
At Modi Ventures, we call this framework the BioStack.
understanding biology as a technology stack
Just as modern computing is built upon layers—from transistors to operating systems to applications—biology can be understood as an interconnected stack of information and function.
DNA stores information.
DNA
DNA stores information.
RNA
RNA translates information.
Protein
Proteins execute biological functions.
Cell
Cells organize those functions into living systems.
Tissue, organ, human
Tissues, organs, and humans emerge from those cellular interactions.
Each layer depends on the one beneath it.
A change at one level can propagate through the entire system.
the BioStack provides a framework for understanding where innovation occurs, how technologies interact, and where new companies can create lasting value.
the biological information flow
DNA > RNA > Protein > Cell >
Tissue > Organ > Human
Historically, scientists could observe these layers.
Today, we can increasingly engineer them.
from observation to engineering
For much of modern medicine, biology was largely descriptive.
Researchers studied disease, identified patterns, and developed therapies designed to manage symptoms.
The ability to intervene directly within biological systems was limited.
That is changing.
Technologies such as next-generation sequencing, CRISPR gene editing, synthetic biology, machine learning, single-cell analysis, spatial biology, and cellular reprogramming are allowing us to interact with biology with unprecedented precision.
We are moving from understanding biology to programming biology.
This transition represents one of the largest technological shifts in human history.
Read. Write. Reprogram.
Our investment philosophy centers around three foundational capabilities.
-
1 Read
The first challenge is understanding biology.
Sequencing technologies, molecular diagnostics, imaging systems, sensors, and AI-driven analytical platforms allow us to observe biological systems with increasing depth and resolution.
Every breakthrough begins with better information.
-
2 Write
Once we understand biology, we can begin to modify it.
Gene editing, synthetic biology, engineered proteins, RNA therapeutics, and computational drug design are enabling scientists to create entirely new biological capabilities.
Biology is becoming a programmable substrate.
-
3 Reprogram
The ultimate frontier is control.
Cellular reprogramming, regenerative medicine, engineered immune systems, and adaptive biological platforms allow us to fundamentally alter the behavior of living systems.
Rather than treating disease after it occurs, we can increasingly redesign the underlying biology itself.
the convergence of AI and biology
Artificial intelligence and biology are often discussed as separate industries.
We believe this is a mistake.
They are rapidly becoming inseparable.
Biology is fundamentally an information system. DNA is digital. Cells process information. Proteins execute instructions. Disease often emerges when biological information is corrupted or misinterpreted.
Artificial intelligence provides a new way to model, predict, and manipulate these systems. The same computational advances that transformed finance, software, and the internet are now being applied to biology.
As a result, the boundaries between technology and life sciences are collapsing.
The future belongs to companies operating at that intersection.
investing across the BioStack
We seek opportunities across the full architecture of life. This includes technologies that:
- Generate biological data
- Interpret biological information
- Design biological systems
- Engineer therapeutic interventions
- Manufacture biological products
- Reprogram cells and tissues
- Extend healthy human lifespan
Rather than viewing healthcare, biotechnology, AI, diagnostics, therapeutics, and computational biology as separate categories, we view them as interconnected layers within a single system.
The most transformative companies often emerge where these layers converge.
The future of biomedicine
At its core, disease can often be viewed through a simple lens.
Cells are either lost. Or cells malfunction.
If cells are lost, we can replace them. If cells malfunction, we can repair or reprogram them.
The technologies required to accomplish this are becoming increasingly available.
What once seemed impossible is rapidly becoming inevitable.
The result is a future where medicine evolves from managing disease to curing disease. From treatment to prevention. From intervention to design.
Our Vision
We believe humanity is entering an era where biology becomes an engineering discipline.
Just as software transformed the digital world, programmable biology will transform the physical world.
The next generation of iconic companies will not simply build software. They will build the infrastructure, platforms, and systems that enable humanity to understand and engineer life itself.
The BioStack is our framework for identifying those opportunities.
It is how we think about science. It is how we think about investing. And ultimately, it is how we think about the future.
Because the most powerful technology platform ever created is not the computer.
It is biology.